Recruiting people at risk of Parkinson’s disease: comparative data from PPMI Online and HeBA Kassel
Objective: To compare a US- and Germany-based staged screening process to identify people at risk of developing Parkinson’s disease (PD). Background: The Parkinson’s Progression Marker…Subject-specific investigation of pathways underlying therapeutic outcomes of deep brain stimulation for Essential Tremor
Objective: To relate subject-specific pathway activation models of motor thalamic deep brain stimulation (DBS) to clinical outcomes in patients with Essential Tremor (ET). Background: Computational…iCARE-PD: a multinational multicenter feasibility study of Integrated Care Networks in Parkinson disease
Objective: To evaluate the implementation of a novel pragmatic care delivery model for people living with Parkinson’s disease (PwP) Background: The intrinsic complexity of care…Analysis of the relationship between acoustic measures and VHI score
Objective: To examine whether there is a relationship between acoustic measurements extracted from audio recordings of sustained vowel /a/ of PWP and their VHI scores.…Remote monitoring of physical activity in Progressive Supranuclear Palsy (PSP) using wearable sensors
Objective: To remotely monitor physical activity in people with PSP and to correlate it with disease progression on the modified PSP Rating Scale (mPSPRS-21). Background:…TEP-PSP: preliminary results of a therapeutic education program in progressive supranuclear palsy
Objective: To explore the feasibility and satisfaction of a therapeutic education program (TEP) in progressive supranuclear palsy (PSP). Background: PSP is a rare tauopathy with…Regional Pain Syndromes- A potential clinical biomarker of Prodromal Parkinson’s Disease
Objective: To investigate whether regional pain syndromes can be an early clinical biomarker for prodromal PD without motor signs Background: The disease-related changes in Parkinson's…Preliminary Report on the efficacy of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease: Phase IIa double-blind, randomized controlled trial.
Objective: To select the safest and most effective number of repeat doses of allogeneic mesenchymal stem cells (MSC) delivered intravenously to slow the progression of…Distinct temporal and spatial alteration of immunoproteasome in Parkinson’s Disease pathogenesis
Objective: We aimed to investigate the temporal and spatial evolution of immunoproteasome in the central nervous system (CNS) during PD pathogenesis using mouse model. Background:…Making the invisible visible: A qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners
Objective: This study aimed to explore the impact of having an (ex-)partner with young onset Parkinson’s disease (YOPD) on daily life. Background: People with YOPD…
- « Previous Page
- 1
- …
- 291
- 292
- 293
- 294
- 295
- …
- 1554
- Next Page »